AERI
Aerie Pharmaceuticals, Inc.
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
182 hedge funds and large institutions have $1.83B invested in Aerie Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 78 increasing their positions, 47 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
182
Holders Change
+10
Holders Change %
+5.81%
% of All Funds
4.54%
Holding in Top 10
7
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-22.22%
% of All Funds
0.17%
New
30
Increased
78
Reduced
47
Closed
19
Calls
$33.7M
Puts
$18M
Net Calls
+$15.8M
Net Calls Change
+$17.9M
Top Buyers
Top Sellers
| 1 |
O
OrbiMed
New York
|
$69.9M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
$149M |
| 3 |
DM
Deerfield Management
New York
|
$30.7M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$4.74M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
$0 |
